Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1977 Dec;18(3):863–865. doi: 10.1128/iai.18.3.863-865.1977

Interferon induction by vesicular stomatitis virus and its role in virus replication.

J Vilcek, S Yamazaki, E A Havell
PMCID: PMC421314  PMID: 201569

Abstract

Antibody against human fibroblast interferon increased the yields of vesicular stomatitis virus in human cells. The results show that endogenous interferon produced in the course of multicycle vesicular stomatitis virus infection depresses virus yields.

Full text

PDF
863

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davey M. W., Sulkowski E., Carter W. A. Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interaction. Biochemistry. 1976 Feb 10;15(3):704–713. doi: 10.1021/bi00648a039. [DOI] [PubMed] [Google Scholar]
  2. Fauconnier B. Enhancing effect of interferon antiserum on viral growth. Nature. 1969 Apr 12;222(5189):185–186. doi: 10.1038/222185a0. [DOI] [PubMed] [Google Scholar]
  3. Gresser I., Tovey M. G., Bandu M. E., Maury C., Brouty-Boyé D. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med. 1976 Nov 2;144(5):1305–1315. doi: 10.1084/jem.144.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gresser I., Tovey M. G., Maury C., Bandu M. T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med. 1976 Nov 2;144(5):1316–1323. doi: 10.1084/jem.144.5.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185–2187. doi: 10.1073/pnas.72.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Havell E. A., Vilcek J., Falcoff E., Berman B. Suppression of human interferon production by inhibitors of glycosylation. Virology. 1975 Feb;63(2):475–483. doi: 10.1016/0042-6822(75)90320-7. [DOI] [PubMed] [Google Scholar]
  7. Marcus P. I., Sekellick M. J. Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature. 1977 Apr 28;266(5605):815–819. doi: 10.1038/266815a0. [DOI] [PubMed] [Google Scholar]
  8. Tan Y. H., Schneider E. L., Tischfield J., Epstein C. J., Ruddle F. H. Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state. Science. 1974 Oct 4;186(4158):61–63. doi: 10.1126/science.186.4158.61. [DOI] [PubMed] [Google Scholar]
  9. Vilcek J., Havell E. A. Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3909–3913. doi: 10.1073/pnas.70.12.3909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wagner R. R., Huang A. S. Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology. 1966 Jan;28(1):1–10. doi: 10.1016/0042-6822(66)90300-x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES